Pharmabiz19h
SA Ramesh has been elected president of TNCDA; KK Selvan secretary
SA Ramesh has been elected president of TNCDA; KK Selvan secretary: Peethaambaran Kunnathoor, Chennai Wednesday, October 9, ...
Pharmabiz15h
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...
Pharmabiz12h
ModeX Therapeutics secures $35 mn BARDA supplement to develop Covid multispecific antibodies and $16 mn to initiate influenza programme
Weston, Massachusetts Wednesday, October 9, 2024, 15:00 Hrs [IST] ...
Pharmabiz13h
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting: London, UK Wednesday, October 9, 2024, 14:0 ...
Pharmabiz9h
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS: Copenhagen, Denmark Wednesday, October 9, 20 ...
Pharmabiz11h
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma: Our Bureau, Bengaluru Wednesday, October 9, 2024, 16:45 Hr ...
Pharmabiz10h
NIHR and the Office for Life Sciences fund new projects to drive earlier diagnosis of cancer
The NIHR and the Office for Life Sciences (OLS) have funded six projects through NIHR's Invention for Innovation (i4i) and the OLS Cancer Programme. These six projects are receiving almost £11 million ...
Pharmabiz18h
Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH for survodutide
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health., announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for ...
Pharmabiz19h
Karnataka's GCC policy strengthens its ecosystem for drug and medical device product conceptualization
Karnataka's GCC policy strengthens its ecosystem for drug and medical device product conceptualization: Nandita Vijayasimha, Bengaluru Wednesday, October 9, 2024, 08:00 Hrs [IST] ...
Pharmabiz11h
Dozee Shravan, an AI-powered remote parent health monitoring service launched for NRIs
Dozee Shravan, an AI-powered remote parent health monitoring service launched for NRIs: Our Bureau, Bengaluru Wednesday, October 9, 2024, 16:15 Hrs [IST] Dozee, India’s health A ...
Pharmabiz13h
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy: Jakarta, Indonesia Wednesday, October 9, 2024, 14:30 Hrs [IST] Roy ...
Pharmabiz14h
The Roquette Foundation for Health announces the winner of its 3rd Research Prize in the field of health prevention
The Roquette Foundation for Health has awarded its 3rd Research Prize to scientist Delphine Payros and her team, for their work on the toxicity of multiple dietary exposures involving mycotoxins in ...